학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 10건 | 목록 1~10
Academic Journal
In: Antioxidants and Redox Signaling. (Antioxidants and Redox Signaling, 1 August 2021, 35(4):252-269)
Academic Journal
Sills, J.Gleick, P.H.Adams, R.M.Amasino, R.M.Anders, E.Anderson, D.J.Anderson, W.W.Anselin, L.E.Arroyo, M.K.Asfaw, B.Ayala, F.J.Bax, A.Bebbington, A.J.Bell, G.Bennett, M.V.L.Bennetzen, J.L.Berenbaum, M.R.Berlin, O.B.Bjorkman, P.J.Blackburn, E.Blamont, J.E.Botchan, M.R.Boyer, J.S.Boyle, E.A.Branton, D.Briggs, S.P.Briggs, W.R.Brill, W.J.Britten, R.J.Broecker, W.S.Brown, J.H.Brown, P.O.Brunger, A.T.Cairns Jr., J.Canfield, D.E.Carpenter, S.R.Carrington, J.C.Cashmore, A.R.Castilla, J.C.Cazenave, A.Chapin III, F.S.Ciechanover, A.J.Clapham, D.E.Clark, W.C.Clayton, R.N.Coe, M.D.Conwell, E.M.Cowling, E.B.Cowling, R.M.Cox, C.S.Croteau, R.B.Crothers, D.M.Crutzen, P.J.Daily, G.C.Dalrymple, G.B.Dangl, J.L.Darst, S.A.Davies, D.R.Davis, M.B.De Camilli, P.V.Dean, C.Defries, R.S.Deisenhofer, J.Delmer, D.P.Delong, E.F.Derosier, D.J.Diener, T.O.Dirzo, R.Dixon, J.E.Donoghue, M.J.Doolittle, R.F.Dunne, T.Ehrlich, P.R.Eisenstadt, S.N.Eisner, T.Emanuel, K.A.Englander, S.W.Ernst, W.G.Falkowski, P.G.Feher, G.Ferejohn, J.A.Fersht, A.Fischer, E.H.Fischer, R.Flannery, K.V.Frank, J.Frey, P.A.Fridovich, I.Frieden, C.Futuyma, D.J.Gardner, W.R.Garrett, C.J.R.Gilbert, W.Goldberg, R.B.Goodenough, W.H.Goodman, C.S.Goodman, M.Greengard, P.Hake, S.Hammel, G.Hanson, S.Harrison, S.C.Hart, S.R.Hartl, D.L.Haselkorn, R.Hawkes, K.Hayes, J.M.Hille, B.Hökfelt, T.House, J.S.Hout, M.Hunten, D.M.Izquierdo, I.A.Jagendorf, A.T.Janzen, D.H.Jeanloz, R.Jencks, C.S.Jury, W.A.Kaback, H.R.Kailath, T.Kay, P.Kay, S.A.Kennedy, D.Kerr, A.Kessler, R.C.Khush, G.S.Kieffer, S.W.Kirch, P.V.Kirk, K.Kivelson, M.G.Klinman, J.P.Klug, A.Knopoff, L.Kornberg, H.Kutzbach, J.E.Lagarias, J.C.Lambeck, K.Landy, A.Langmuir, C.H.Larkins, B.A.Pichon, X.T.L.E.Lenski, R.E.Leopold, E.B.Levin, S.A.Levitt, M.Likens, G.E.Lippincott-Schwartz, J.Lorand, L.Lovejoy, C.O.Lynch, M.Mabogunje, A.L.Malone, T.F.Manabe, S.Marcus, J.Massey, D.S.Mcwilliams, J.C.Medina, E.Melosh, H.J.Meltzer, D.J.Michener, C.D.Miles, E.L.Mooney, H.A.Moore, P.B.Morel, F.M.M.Mosley-Thompson, E.S.Moss, B.Munk, W.H.Myers, N.Nair, G.B.Nathans, J.Nester, E.W.Nicoll, R.A.Novick, R.P.O'Connell, J.F.Olsen, P.E.Opdyke, N.D.Oster, G.F.Ostrom, E.Pace, N.R.Paine, R.T.Palmiter, R.D.Pedlosky, J.Petsko, G.A.Pettengill, G.H.Philander, S.G.Piperno, D.R.Pollard, T.D.Price Jr., P.B.Reichard, P.A.Reskin, B.F.Ricklefs, R.E.Rivest, R.L.Roberts, J.D.Romney, A.K.Rossmann, M.G.Russell, D.W.Rutter, W.J.Sabloff, J.A.Sagdeev, R.Z.Sahlins, M.D.Salmond, A.Sanes, J.R.Schekman, R.Schellnhuber, J.Schindler, D.W.Schmitt, J.Schneider, S.H.Schramm, V.L.Sederoff, R.R.Shatz, C.J.Sherman, F.Sidman, R.L.Sieh, K.Simons, E.L.Singer, B.H.Singer, M.F.Skyrms, B.Sleep, N.H.Smith, B.D.Snyder, S.H.Sokal, R.R.Spencer, C.S.Steitz, T.A.Strier, K.B.Südhof, T.C.Taylor, S.S.Terborgh, J.Thomas, D.H.Thompson, L.G.Tjian, R.T.Turner, M.G.Uyeda, S.Valentine, J.W.Valentine, J.S.Van Etten, J.L.Van Holde, K.E.Vaughan, M.Verba, S.Von Hippel, P.H.Wake, D.B.Walker, A.Walker, J.E.Watson, E.B.Watson, P.J.Weigel, D.Wessler, S.R.West-Eberhard, M.J.White, T.D.Wilson, W.J.Wolfenden, R.V.Wood, J.A.Woodwell, G.M.Wright Jr., H.E.Wu, C.Wunsch, C.Zoback, M.L.
In: Science. (Science, 7 May 2010, 328(5979):689-690)
Academic Journal
Girerd N; Université de Lorraine, Inserm, Centre d'Investigations Cliniques- Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (N.G., K.D., J.P.F., A.P., A.-C.H., P.R., F.Z.).; Levy D; National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA (D.L., J.H., S.-J.H).; Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (D.L., J.H., S.-J.H.).; Duarte K; Université de Lorraine, Inserm, Centre d'Investigations Cliniques- Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (N.G., K.D., J.P.F., A.P., A.-C.H., P.R., F.Z.).; Ferreira JP; Université de Lorraine, Inserm, Centre d'Investigations Cliniques- Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (N.G., K.D., J.P.F., A.P., A.-C.H., P.R., F.Z.).; Ballantyne C; Baylor College of Medicine, Houston, TX (C.B.).; Collier T; London School of Hygiene and Tropical Medicine, United Kingdom (T.C.).; Pizard A; Université de Lorraine, Inserm, Centre d'Investigations Cliniques- Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (N.G., K.D., J.P.F., A.P., A.-C.H., P.R., F.Z.).; Inserm 1024, Institut de Biologie de l'École Normale Supérieure (IBENS), PSL University of Paris, France (A.P.).; Björkman J; TATAA Biocenter AB, Gothenburg, Sweden (J.B.).; Butler J; Department of Medicine, University of Mississippi School of Medicine, Jackson (J.B.).; Clark A; Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom (A.C.).; Cleland JG; Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing, University of Glasgow, United Kingdom (J.G.C., P.P.).; National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, United Kingdom (J.G.C.).; Delles C; Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (C.D.C.).; Diez J; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (J.D.C., A.G.C.).; CIBERCV, Carlos III Institute of Health, Madrid, Spain (J.D.C., A.G.C.).; González A; CIBERCV, Carlos III Institute of Health, Madrid, Spain (J.D.C., A.G.C.).; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Spain (J.D.C., A.G.C.).; Departments of Nephrology, and Cardiology and Cardiac Surgery, University of Navarra Clinic, Pamplona, Spain (A.G.C.).; Hazebroek M; Department of Cardiology, Maastricht University Medical Centre, Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands (M.H.C.).; Ho J; National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA (D.L., J.H., S.-J.H).; Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (D.L., J.H., S.-J.H.).; Huby AC; Université de Lorraine, Inserm, Centre d'Investigations Cliniques- Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (N.G., K.D., J.P.F., A.P., A.-C.H., P.R., F.Z.).; Hwang SJ; National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA (D.L., J.H., S.-J.H).; Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (D.L., J.H., S.-J.H.).; Latini R; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy (R.L.).; Mariottoni B; Department of Cardiology, Cortona Hospital, Arezzo, Italy (B.M.).; Mebazaa A; UMRS 942; University Paris Diderot; APHP, University Hospitals Saint Louis Lariboisière, France (A.M.).; Pellicori P; Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing, University of Glasgow, United Kingdom (J.G.C., P.P.).; Sattar N; Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (N.S.).; Sever P; International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, United Kingdom (P.S.).; Staessen JA; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S.).; Verdonschot J; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S.).; Heymans S; Department of Cardiovascular Research, University of Leuven, UZ Herestraat, Belgium (S.H.).; Netherlands Heart Institute (ICIN), Utrecht, the Netherlands (S.H.).; Department of Clinical Genetics, Maastricht University Medical Center, the Netherlands (S.H.).; Rossignol P; Université de Lorraine, Inserm, Centre d'Investigations Cliniques- Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (N.G., K.D., J.P.F., A.P., A.-C.H., P.R., F.Z.).; Zannad F; Université de Lorraine, Inserm, Centre d'Investigations Cliniques- Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (N.G., K.D., J.P.F., A.P., A.-C.H., P.R., F.Z.).
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101479941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-3297 (Electronic) Linking ISSN: 19413289 NLM ISO Abbreviation: Circ Heart Fail Subsets: MEDLINE
Academic Journal
Ferreira JP; Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).; Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Portugal (J.P.F.).; Verdonschot J; Department of Cardiology, Maastricht University Medical Centre, Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands (J.V., M.H., S.H.).; Department of Clinical Genetics, Maastricht University Medical Center, the Netherlands (J.V., P.W.).; Collier T; London School of Hygiene and Tropical Medicine, United Kingdom (T.C.).; Wang P; Department of Clinical Genetics, Maastricht University Medical Center, the Netherlands (J.V., P.W.).; Pizard A; Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).; Inserm 1024, Institut de Biologie de l'École Normale Supérieure (IBENS), PSL University of Paris, France (A.P.).; Bär C; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany (C.B., T.T.).; Björkman JBoccanelli A; Casa di Cura Quisisana, Rome, Italy (A.B.).; Butler J; TATAA Biocenter AB, Gothenburg, Sweden (J.B.).; Department of Medicine, University of Mississippi School of Medicine, Jackson (J.B.).; Excellence Cluster REBIRTH, Hannover Medical School, Germany (J.B.).; Clark A; Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom (A.C.).; Cleland JG; Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing, Glasgow, United Kingdom (J.G.C.).; National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, University of Glasgow, London, United Kingdom (J.G.C.).; Delles C; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, United Kingdom (C.D.).; Diez J; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (J.D., A.G.).; CIBERCV, Carlos III Institute of Health, Madrid, Spain (J.D., A.G.).; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Spain (J.D., A.G.).; Departments of Nephrology, and Cardiology and Cardiac Surgery, University of Navarra Clinic, Pamplona, Spain (J.D.).; Girerd N; Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).; González A; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (J.D., A.G.).; CIBERCV, Carlos III Institute of Health, Madrid, Spain (J.D., A.G.).; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Spain (J.D., A.G.).; Hazebroek M; Department of Cardiology, Maastricht University Medical Centre, Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands (J.V., M.H., S.H.).; Huby AC; Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).; Jukema W; Department of Cardiology, Leiden University Medical Center, the Netherlands (W.J.).; Latini R; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy (R.L.).; Leenders J; ACS Biomarker BV, Amsterdam, the Netherlands (J.L.).; Levy D; National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, MA (D.L.).; Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (D.L.). UMRS 942, University Paris Diderot.; Mebazaa A; APHP, University Hospitals Saint Louis Lariboisière, France (A.M., N.V.).; Mischak H; Mosaiquesdiagnostics, Hannover, Germany (H.M.).; Pinet F; Inserm U1167, Institut Pasteur de Lille, Université de Lille, FHU-REMOD-VHF, France (F.P.).; Rossignol P; Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).; Sattar N; Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (N.S.).; Sever P; International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, England (P.S.).; Staessen JA; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S., Z.-Y.Z.).; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, the Netherlands (J.A.S.).; Thum T; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany (C.B., T.T.).; National Heart and Lung Institute, Imperial College London, United Kingdom (T.T.).; Vodovar N; APHP, University Hospitals Saint Louis Lariboisière, France (A.M., N.V.).; Zhang ZY; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S., Z.-Y.Z.).; Heymans S; Department of Cardiology, Maastricht University Medical Centre, Center for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands (J.V., M.H., S.H.).; Department of Cardiovascular Research, University of Leuven, Belgium (S.H.). Netherlands Heart Institute (ICIN), Utrecht, the Netherlands (S.H.).; Zannad F; Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., A.P., N.G., A.-C.H., P.R., F.Z.).
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101479941 Publication Model: Print Cited Medium: Internet ISSN: 1941-3297 (Electronic) Linking ISSN: 19413289 NLM ISO Abbreviation: Circ Heart Fail Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Bjorkman, S.H.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어